Miami Jackson Memorial Hospital is a non-profit, tertiary care teaching hospital and the major teaching hospital of the University of Miami Leonard M. Miller School of Medicine located in Miami, in the United States. The hospital currently has approximately 1,550 licensed beds.

There are 1,550 beds in Jackson Memorial Hospital.

During the past decade, Jackson Memorial Hospital conducted 47 clinical trials. In the 10-year time frame, 47 clinical trials started and 26 clinical trials were completed, i.e. on average, 55.3% percent of trials that started reached the finish line to date. In the past 5 years, 20 clinical trials started and 13 clinical trials were completed. i.e. 65% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Jackson Memorial Hospital" #1 sponsor was "University of Miami" with 27 trials, followed by "Children's Oncology Group" with 9 trials sponsored, "Acacia Pharma Ltd" with 3 trials sponsored, "Actelion" with 3 trials sponsored and "Genentech, Inc." with 3 trials sponsored. Other sponsors include 54 different institutions and companies that sponsored additional 51 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Jackson Memorial Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 13 trials as a collaborator, "National Institute of Neurological Disorders and Stroke (NINDS)" with 7 trials as a collaborator, "Medical University of South Carolina" with 5 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 3 trials as a collaborator and "National Institute on Drug Abuse (NIDA)" with 3 trials as a collaborator. Other collaborators include 61 different institutions and companies that were collaborators in the rest 62 trials.

According to Clinical.Site data, the most researched conditions in "Jackson Memorial Hospital" are "Stroke" (5 trials), "Breast Cancer" (3 trials), "Covid19" (3 trials), "Leukemia" (3 trials) and "Pulmonary Embolism" (3 trials). Many other conditions were trialed in "Jackson Memorial Hospital" in a lesser frequency.

Most popular intervention types in "Jackson Memorial Hospital" are "Drug" (55 trials), "Device" (20 trials), "Other" (13 trials), "Biological" (12 trials) and "Behavioral" (11 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (19 trials), "cyclophosphamide" (5 trials), "filgrastim" (5 trials), "radiation therapy" (5 trials) and "conventional surgery" (4 trials). Other intervention names were less common.

The vast majority of trials in "Jackson Memorial Hospital" are 101 trials for "All" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "Jackson Memorial Hospital". 2 are not yet recruiting, 14 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 66 completed trials in Jackson Memorial Hospital, undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in Jackson Memorial Hospital, 3 "Phase 1" clinical trials were conducted, 17 "Phase 2" clinical trials and 42 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 27 trials that are defined as “Not Applicable".

Jackson Memorial Hospital has several departments that took part in Clinical trials: "Jackson Memorial Hospital-Holtz Children's Hospital" - 24 trials, "NICU at Holtz Children's Hospital" - 2 trials